Bank of Montreal’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Bank of Montreal's PFE Position: Q1 2026 in Review
Bank of Montreal reduced its Pfizer (PFE) stake by 20% in Q1 2026, selling an estimated $52.6M and leaving 7,667,405 shares worth $215M. The position accounts for 0.08% of the portfolio, ranked #199.
Bank of Montreal first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $971M in Q3 2018. 2,941 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bank of Montreal held 7,667,405 shares of Pfizer worth $215M as of Q1 2026.
- Bank of Montreal sold 1,975,174 Pfizer shares in Q1 2026, an estimated $52.6M.
- Pfizer made up 0.08% of Bank of Montreal's portfolio in Q1 2026, its #199 holding.
- Bank of Montreal first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bank of Montreal's Pfizer position peaked at $971M in Q3 2018.
- 2,941 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.